Mitovation, Inc.

Ann Arbor, MI · Founded 2016 · CIK 0001767738 · Medtech · Private

Mitochondrial modulation therapy platform for treating brain injuries

mitovation.com →
Grants
$4.6M
4 awards
Sector median: 1
Raised
$500K
1 Form D · Feb 2019
92 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$248,042
Private capital raisedForm D · SEC$500,000
Federal grantDepartment of Health and Human Services · Phase II · Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$1,571,975
Federal grantDepartment of Health and Human Services · Phase II · Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$768,981
Federal grantDepartment of Health and Human Services · Phase I · Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest$1,985,893
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1528CAMELLIX, LLC——
1529Apex Cool Labs, Inc.—$65K
1530FLUIDION US Inc——
1531Mitovation, Inc.—$500K
1532NeurInsight, LLC——
1533PinkDx, Inc.—$17M
1534Tactile Analogics LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Maik Huttemann, Ph.DDirector
  • Mark MorsfieldDirector · Executive Officer
  • Thomas Sanderson, Ph.D.Director

Patents

USPTO · 0 granted of 1
  • Systems And Methods For Treating Ischemic-reperfusion And Other Injuries Using A Waveguideapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.